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Abstract The Disease Ontology (DO) enables cross-do-
main data integration through a common standard of
human disease terms and their etiological descriptions.
Standardized disease descriptors that are integrated across
mammalian genomic resources provide a human-readable,
machine-interpretable, community-driven disease corpus
that unifies the representation of human common and rare
diseases. The DO is populated by consensus-driven disease
data descriptors that incorporate disease terms utilized by
genomic and genetic projects and resources engaged in
studies to understand the genetics of human disease
through the study of model organisms. The DO project
serves multiple roles for the model organism community
by providing: (1) a structured ‘‘backbone’’ of disease
concepts represented among the model organism data-
bases; (2) authoritative disease curation services to
researchers and resource providers; and (3) development of
subsets of the DO representative of human diseases anno-
tated to animal models curated within the model organism
databases.
Introduction
The nomenclature of human disease has a long and com-
plex history. Traditionally, diseases have been named for
the discoverer of the disease (Robinow syndrome), where
the disease was first discovered (Rocky Mountain spotted
fever), or the animal in which the disease was first iden-
tified (avian influenza). A disease may initially be called a
syndrome to describe a collection of symptoms. As genes,
genetic variants and the etiology of a disease are discerned;
the disease name may or may not be changed to reflect the
new level of knowledge. Consequently, there is a signifi-
cant need for a standardized representation of human dis-
eases to map disease concepts across resources, to connect
related information, and to support the development of
computational tools that will enable robust data analysis
and integration. Utilizing a standardized ontological rep-
resentation of human diseases creates a rigorous knowledge
backbone for the annotation of biomedical data through
defined concepts connected by specified relations
(Hoehndorf et al. 2012; Musen et al. 2012). The Disease
Ontology (DO) (Schriml et al. 2012; Kibbe et al. 2015) was
developed to connect clinical vocabulary concepts through
the creation of a single unifying representation of human
disease. The DO simplifies and facilitates the exchange and
comparison of disease-related information between
biomedical and clinical resources. The scope of this review
is to highlight the roles of the DO project contributing to
human disease and mammalian genetic research, specifi-
cally describing the DO’s activities to support mouse
model organism research at the mouse genome informatics
(MGI) database. The DO project provides on-going expert
curation of human diseases annotated within the model
organism databases (MOD) (Kibbe et al. 2015) and has
begun to create MOD-specific subsets of DO to facilitate
the use of DO within the MODs. The DO team has created
a DO_MGI_slim as a subset of the DO for human disease
terms associated with mouse animal models within MGI. A
slim of the DO is a smaller version of the DO’s Human-
DO.obo file that contains a subset of terms from the entire
DO file.
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DO: a centralized disease term resource
The DO provides a homogeneous, centralized ontological
representation of human disease that fosters precise iden-
tification and interpretation of disease data elements and
incorporates the changing nomenclature of human disease
terms over time along with community-specific naming
conventions and synonyms.
The DO project was established in 2003 at Northwestern
University to address the need for a purpose-built ontology
that covers the full spectrum of disease concepts annotated
within biomedical repositories within an ontological
framework that is extensible to meet community needs.
Disease concepts are defined for a variety of reporting and
indexing purposes that are represented in numerous medi-
cal vocabularies. The DO was initially built from the union
of disease terms extracted from the ICD mortality and
morbidity classifications (Ayme et al. 2010), SNOMED-
CT clinical and event healthcare reports (Donnelly 2006),
and MeSH Medline index terms (Nelson et al. 2004; Kibbe
et al. 2015). Expansion of disease sub-types has been dri-
ven by the disease data needs of the user community. The
DO team works with several MODs to integrate their
human disease terms into DO. The DO project additionally
integrates human disease terms represented in biomedical
resources including the Online Mendelian Inheritance in
Man (OMIM) (Amberger et al. 2015), the experimental
factor ontology (EFO) (Parkinson et al. 2011), the protein
ontology (PRO) (Natale et al. 2014), and orphanet (Ayme
et al. 2010) to provide authoritative and rigorously
reviewed disease terms. DO’s inclusion of unique identi-
fiers from the medical vocabularies facilitates cross-map-
ping between resources and enables the DO team to
quickly identify and avoid inclusion of overlapping (not
novel) content.
DO development and content
As a community-driven standards-based ontology project,
the DO is focused on representing common and rare dis-
ease concepts captured across biomedical resources with
the mission of providing a broadly useful disease interface
between data resources through on-going support (term
review and integration) of disease terminology needs. The
DO includes 6582 terms (38 % defined, revision 2821)
representing inherited, developmental, and acquired human
diseases. The HumanDO.obo file additionally includes the
set of 2373 obsoleted DO terms to enable ID tracking. As
terms are added or reviewed within the DO, textual defi-
nitions are added. The DO team is actively working to
define all terms within DO. We have increased the percent
of defined DO terms by 16 % since 2012. This includes the
addition of 163 DO terms and an increase of defined DO
terms by 6 % overall between October 2014 and May
2015. The DO team will continue to address the need to
add definitions for our backlog of undefined terms.
DO: representation of disease terms
DO disease descriptors represent individual disease terms
and are provided in a computable format where each DO
term is represented by unique uniform resource identifiers
(URI’s) (e.g., http://www.purl.obolibrary.org/obo/DOID_
4). A DOID is a disease ontology ID. The DO’s Human-
DO.obo file can be downloaded from our Sourceforge
repository at: http://www.sourceforge.net/p/diseaseontology/
code/HEAD/tree/trunk/HumanDO.obo. The OWL version
of the HumanDO file, produced by the OBO Foundry, can
be found at: http://www.purl.obolibrary.org/obo/doid.owl.
The DO project publishes our primary data files and soft-
ware in public repositories to ensure that they will remain
publicly available. While maintaining DO’s Sourceforge
archive (http://www.sourceforge.net/p/diseaseontology) for
current DO users, the DO project has began to transition our
production activities to a GitHub repository (http://www.
github.com/obophenotype/human-disease-ontology) in 2015.
The DO project’s ontology and database files are freely
available for copying, redistribution, and adaption for any
purpose under the Creative Commons Attribution 3.0
Unported License (http://www.creativecommons.org/licen
ses/by/3.0/).
The DO website (http://www.disease-ontology.org)
contains a web-based application (Fig. 1) that enables full-
text searching of DO disease terms, definitions, and related
metadata. The DO includes a subset of terms utilized
within MGI. The set of MGI human disease terms can be
retrieved through the DO web interface by searching on the
slim name DO_MGI_slim in the search box or as an
Advanced Search by selecting subset. This query will
retrieve the set of disease terms utilized for the annotation
of human diseases for mouse animal models in MGI.
Additionally, the set of DO diseases with an associated
OMIM cross-reference can be retrieved by an Advanced
Search of Xrefs and typing in OMIM to the query box.
The DO web browser’s RESTful API service enables
direct querying of a single DOID (e.g., sick sinus syndrome
http://www.disease-ontology.org/term/DOID:13884/) and
programmatic access of the DO database metadata (http://
www.disease-ontology.org/api/metadata/DOID:13884) to
produce:
{‘‘xrefs’’: [‘‘ICD10CM:I49.5’’, ‘‘MSH:D012804’’, ‘‘NCI:
C62244’’, ‘‘OMIM:163800’’, ‘‘OMIM:608567’’, ‘‘OMIM:





C0037052’’], ‘‘name’’: ‘‘sick sinus syndrome’’, ‘‘subsets’’:
[‘‘DO_MGI_slim’’], ‘‘synonyms’’: [‘‘sinus node infection
EXACT ‘‘], ‘‘parents’’: [[‘‘is_a’’, ‘‘sinoatrial node disease’’,
‘‘DOID:0050824’’]], ‘‘id’’: ‘‘DOID:13884’’}.
DO: disease curation service and community
collaborations
The DO project established a user support workflow in 2007
to invite DO users to submit DO term requests and updates.
The DO team reviews, classifies, and integrates requested
terms into DO. The DO team has established curation ‘best
practices’ to field and respond to user requests, to coordinate
disease representation within biomedical resources, and to
provide subject matter and ontology expert curation
guidance to the user community. DO curator’s Style Guide
is available on the DO website under the Resources tab. The
DO Style Guide provides documentation on defining new
terms, cleaning up term format, creating definitions, dbxrefs
(IDs as references to external resources), and provenience of
term definition sources as URLs.
The DO project has established a network of collabo-
rative disease annotation efforts where the community
members contribute their expertise and area-specific dis-
ease content to DO and the DO team provides expert dis-
ease classifications to the community members (Kibbe
et al. 2015). These on-going efforts ensure the accuracy of
DO annotations through on-going community review and
feedback provided to DO. Additionally, the DO team
receives novel disease terms, suggestions, and advices from
subject matter experts in an on-going weekly, sometimes
daily, process. For example, the neuroscience information
framework (NIF) (Imam et al. 2012) and NeuroDevNet
(Portales-Casamar et al. 2013) have been major
Fig. 1 The disease ontology website. A query for all DO terms included in the DO_MGI_slim is displayed
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contributors to DO’s representation of neurological dis-
eases. The DO project collaborates with a number of NIH-
funded genomic resources including: MGI, Protein Ontol-
ogy (PRO), the Immune Epitope Database (IEDB), Reac-
tome, WormBase (Harris et al. 2014), FlyBase (Dos Santos
et al. 2015), and the NHLBI LINCS project (Vempati et al.
2014). For example, the Reactome project (Croft et al.
2014) has a total of 1226 pathways and reactions (out of
120,965 total human reactions and pathways) that are
annotated with a DO disease term, and 2167 proteins and
complexes (out of 40,349 human proteins and complexes)
annotated with one.
MGI: Disease Ontology collaboration
The DO project teamed up with MGI in the fall of 2014 to
provide review and integration of MGI’s genetic disease
vocabulary terms (aligned to OMIM terms and IDs) into
DO. The DO is being enriched by the novel content con-
tributed by MGI representing genetic disease sub-types
associated with new mouse models and recently reported
human diseases. The MGI team generated and provided
DO with a mapping file of 2606 disease terms with cor-
responding OMIM IDs. Manual review of each disease
term and OMIM mapping identified a set of 1198 OMIM
IDs that mapped to 260 existing DO terms and a set of
1408 OMIM IDs that had no corresponding DOIDs. These
1408 OMIM IDs were mapped to new DO terms. In total,
250 new DO terms were created, primarily representing
syndromes and rare diseases. The DO term to OMIM ID
mapping identified several one to many mappings between
DOIDs and OMIM IDs. This work represents a substantial
multi-month manual curation effort and highlights the
importance of the manual reviews required to connect
biological concepts. Automated mapping of disease terms
between resources and vocabularies holds the promise of
streamlining manual reviews (Rance et al. 2013). The DO
project recognizes the potential of automated mapping of
disease terms. However, the DO project has been cautious
to integrate automated analysis into our workflow, as the
precision (the proportion of true positives that are correctly
identified as true positives) of these analyses is less than
100 %. This manual review process included: the
reassessment of the hierarchy of each term; the re-evalua-
tion of its definition, if one existed; the definition of the
term, if one didn’t exist; addition of synonyms; and map-
ping of the term to other sources (ICD10 codes, Orphanet
IDs) via cross-references. A small number of OMIM terms
could not be included in DO as they represent a phenotype
but not a disease such as the OMIM entries: ‘‘Plasmodium
falciparum blood infection level’’ (OMIM: 248310);
‘‘Plasmodium falciparum quantitative trait locus 1’’
(OMIM:611384), and ‘‘susceptibility to migraine, with or
without aura’’ (OMIM:610208).
DO: an ontology and resource disease hub
The DO has been widely adopted and utilized as a standard
representation of human disease in biomedical ontologies
including the human phenotype ontology (HPO; Ko¨hler
et al. 2014), the infectious disease ontology (IDO; http://
www.infectiousdiseaseontology.org), the influenza ontol-
ogy, the NIFSTD ontology, the cell ontology (CL), the
experimental factor ontology (EFO), the protein ontology
(PRO), and the cardiovascular disease ontology (https://
www.code.google.com/p/cvdo/). The DO has become a
highly utilized disease data resource for evaluating and
connecting diverse sets of data. DO terms are being utilized
for identifying representative phenotype sets (Ko¨hler et al.
2014; Schofield et al. 2010; Monarch Initiative http://www.
monarchinitiative.org and HPO Phenomizer http://www.
compbio.charite.de/phenomizer/) and functionally similar
genes (Fang and Gough 2013; Singleton et al. 2014). The
DO is also being used for analyzing ontologies and protein
domain annotations (dcGOR (Fang 2014)), human gene
and genome annotations (Peng et al. 2013; Osborne et al.
2009), pathways (Croft et al. 2014; Hoehndorf et al. 2012),
cancer variants (Wu et al. 2014; Milacic et al. 2012), and
immune epitopes (Vita et al. 2014).
The extensive use of DO in data analysis workflows and
the annotation of DO terms across a wide body of genomic
resources enables users to readily identify data of interest
within or between these resources and to identify novel
connections. For example, the Jackson Laboratory for
Genomic Medicine is utilizing DO within their Clinical
Genome Informatics System workflow to collect clinical
disease data and to translate pathology reports to Next
Generation Sequencing Clinical Reports (Ananda et al.
2015). Likewise, the BioXpress, a gene expression and
cancer association database, is utilizing DO to map cancer
terms across cancer resources to facilitate uniform pan-
cancer analysis (Wan et al. 2015).
DO subsets: resource-specific disease
representations (DO slims)
By definition biomedical ontologies capture the breadth of
domain specific knowledge. In order to take further
advantage of the detailed ontological information found in
the leaf ontology terms subsets of biomedical ontologies,
called slims, are being created to provide customized high-
level views (Davis et al. 2010; Geifman et al. 2010). For
example, subsets of the gene ontology (GO) (GO
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Consortium 2013) have been created (http://www.geneon
tology.org/page/go-slim-and-subset-guide) to represent model
organism or resource-specific subsets of GO. The DO
project initiated the development of DO slims in 2014 to
provide resource- (e.g., MGI) or disease-specific (e.g.,
cancer) subsets of DO. DO slim files can be extracted from
the DO HumanDO.obo file and are also are available as
from DO’s GitHub repository (https://www.github.com/
obophenotype/human-disease-ontology).
The DO_MGI_slim represents a focused view of the subset
of genetic diseases in DO that are represented in MGI and
enables researchers to identify and explore mouse model
organism associated diseases. The DO_MGI_slim subset cur-
rently contains 354 terms (DO revision 2821). Additional terms
are being reviewed for inclusion in DO from a set of 510 MGI
human disease terms. DO slim files are available from the DO
SVN repository.
The DO_cancer_slim provides a broad view of the set of
DO cancer terms represented within the catalog of somatic
mutations in cancer (COSMIC), the international cancer gen-
ome consortium (ICGC), the cancer genome atlas (TCGA),
and the integrative oncogenomics (IntOGen) database to sup-
port the coordinated effort of pan-genome analysis of cancer
genetic variants (Wu et al. 2015). The DO_cancer_slim rep-
resents the classification of a subset of 393 cancer terms into a
cohesive set of 192 DO terms. This collaborative classification
of cancer terms resulted in 43 new cancer terms being added to
DO and the addition of definitions and references for 63 DO
parent terms and 187 DO child node (leaf) terms. The DO_
cancer_slim terms were further categorized by the type of
cancer they represent into a selection of 64 upper-level DO
terms (TopNodes_DOcancerslim). This project has produced a
unifying ontology of cancer terms that could be used to map
data across various resources, representing a multitude of
cancer types, and be utilized for pan-cancer analysis.
Conclusions
The DO project is highly committed in our efforts to support
genetic and genomic research as disease data and curation
resource. As a centralized disease resource DO provides
stable, long-term support of disease terms to be used by the
MOD research community. The DO team provides reliable
and responsive curation services to researchers and data
providers. Requests for DO curation may be submitted
through the DO website (http://www.disease-ontology.org),
DO’s SVN term tracker (http://www.sourceforge.net/p/dis
easeontology/feature-requests/), DO’s Contact Us web form,
or by emailing the DO team members (email: DO PI - Lynn
Schriml: lschriml@som.umaryland.edu).
The DO project will be creating additional DO slims for
each of the MODs (e.g., Reactome, FlyBase, WormBase,
RGD, SGD, and ZFIN) in the near future. These subsets of
the DO will enable DO users to review the representation
and classification of associated diseases, to compare the
diseases represented between MODs and to compare the
different animal models associated with a particular disease
or types of diseases across species.
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